Perspective · 4 Mar 2025
Research articlePublished 2016
Inhibition of Tumors in Mice Models by a Synthetic Ceramide-analog AD2725
Abstract
A synthetic analog of ceramide (AD2725) elevated ceramide levels in MDA-MB-435 breast cancer cells inducing apoptosis and resulted in cell death. In animal studies, using a model of xenograft breast cancer cells in nude mice, treatment with AD2725 resulted in a significant reduction of the tumor volume and weight, and significantly prolonged survival of the treated mice. The analog also significantly elevated INF gamma and IL-12 cytokine levels and reduced the level of IL-10 in the plasma. These data indicate that use of suitable synthetic analogs that most probably elevate the ceramide levels may have beneficial anti-cancer therapeutic effects.
Subjects
Pharmaceutical SciencesMore from this journal
The newest in Biochemistry & Pharmacology: Open Access.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalBiochemistry & Pharmacology: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Qin JD”
- BylineArticles whose byline prints “Weiss L”
- BylineArticles whose byline prints “Zeira M”
- BylineArticles whose byline prints “Yekhtin Z”
- BylineArticles whose byline prints “Slavin S”
- BylineArticles whose byline prints “Gatt S”
- BylineArticles whose byline prints “Dagan A”
